Cholesterol efflux capacity is associated with inflammation level and monocyte-platelet aggregates in healthy men.

Background and Aims: It is well established that HDL particles have antiatherogenic properties. However, there are conflicting evidence in regards to HDL particle function and its association with various CVD risk factors. The aim of our study was to analyze associations between the marker of HDL function - cholesterol efflux capacity (CEC) and traditional (age, serum lipids, CRP) and emerging (monocyte-platelet aggregates (MPAs)) CVD risk markers.